Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01055730 · ClinicalTrials.gov registry record
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 54
- Enrollment target
NCT01055730 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 54 participants.
The verdict
NCT01055730 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if pulmonary rehabilitation has any effect on breathlessness, quality of life, physical function and depression in persons with interstitial lung disease.
Interventions
- OTHER Pulmonary rehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01055730
The ClinicalTrials.gov registry entry for NCT01055730 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulmonary rehabilitation is the first listed.
NCT01055730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01055730 about?
NCT01055730 is a clinical study titled "The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease". The purpose of this study is to determine if pulmonary rehabilitation has any effect on breathlessness, quality of life, physical function and depression in persons with interstitial lung disease.
What is the current status of trial NCT01055730?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2010-02. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01055730?
The interventions under investigation include: Pulmonary rehabilitation (OTHER).
Who is sponsoring clinical trial NCT01055730?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.